L-19-PDT (Philogen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameL-19-PDT (Philogen)

Drug Alias NameVangioluxL-19-PDT

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionIntegrin beta-1 modulators

TargetsIntegrin beta-1

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPhilogen Spa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPhilogen Spa

Active IndicationsN/A

Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A